Pharmaceutical Anti-Counterfeiting Technologies Market

The problem of counterfeit products has been a common challenge to all the industries across the globe. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. This field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry.

Mohali, Punjab, India, July 06, 2015 --(PR.com)-- Roots Analysis has announced the addition of “Pharmaceutical Anti-Counterfeiting Technologies Market, 2015-2025” report to their offering. This study provides extensive details on technologies which offer overt and covert features to enable the verification of drugs. In addition, it reviews different track and trace technologies which enable tracking of a product through the supply chain. Counterfeiting of products is a big concern in several industries such as electronics, cosmetics, tobacco, wine and spirits and fast moving consumer goods. Specifically, within the pharmaceutical market, the magnitude of the problem is relatively high as it has a direct impact on the health of the wider community. It is worth highlighting that the pharmaceutical market is highly attractive for counterfeiters due to several benefits such as high price of patented drugs, lack of proper legislations and high demand of medicines compared to their supply. The primary goal of anti-counterfeiting technologies is to prevent counterfeiting of products; this is done by making it difficult to copy patent protected drugs as well as preventing entry of substandard or fake drugs into the product supply chain.

Arun Gupta, the principal analyst, stated, “In the recent past, the number of counterfeiting incidents have increased. Many companies have developed technologies that help prevent counterfeiting by providing various overt as well as covert security features. In addition, there are many track & trace technologies that help in managing complex pharmaceutical supply chains. Many countries around the world are making it mandatory for pharmaceutical companies to implement serialisation. However, some stakeholders are of the opinion that authentication technologies are much more effective as anti-counterfeiting measures rather than just providing a unique number to each product (the case of serialisation).”

In fact, one of the key objectives of this report is to understand the future state of the industry. We have adopted a scenario based approach to forecast the market for authentication technologies. The adopted approach identifies short-midterm and long term market evolution for the period 2015-2020 and 2020-2025, respectively.”

Gupta added, “Even though there are several challenges to overcome, the anti-counterfeiting technologies market is inundated with huge opportunities. Serialisation technologies are going to be a key factor in determining the future state of the overall market. Our opinion and insights, presented in this study, were influenced by the discussions that we conducted with different ophthalmic implant developers in this industry such as AlpVision, Infratrac, Jura JSP and Sproxil.”

For additional details please visit http://www.rootsanalysis.com/reports/view_document/pharmaceutical-anti-counterfeiting-technologies-market-2015-2025/100.html

or email sales@rootsanalysis.com
Contact
Roots Analysis
Gaurav Chaudhary
+1-604-595-4954
www.rootsanalysis.com
ContactContact
Categories